Nuvation Bio | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Nuvation Bio | 8-K: Nuvation Bio Reports First Quarter 2024 Financial Results and Provides Business Update
Nuvation Bio | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Nuvation Bio | 8-K: Current report
Nuvation Bio | 8-K: Current report
Nuvation Bio | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Nuvation Bio | 8-K: Nuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Nuvation Bio | 8-K: Current report
Nuvation Bio | 8-K: Current report
Nuvation Bio | 8-K: Current report
Nuvation Bio | 8-K: Current report
Nuvation Bio | 8-K: Nuvation Bio Reports Third Quarter 2023 Financial Results and Provides Business Update
Nuvation Bio | 8-K: Nuvation Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
Nuvation Bio | 8-K: Current report
Nuvation Bio | 8-K: Nuvation Bio Reports First Quarter 2023 Financial Results and Provides Business Update
Nuvation Bio | DEF 14A: Definitive proxy statements
Nuvation Bio | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Nuvation Bio | 8-K: Nuvation Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
Nuvation Bio | 8-K: Current report
Nuvation Bio | 8-K: Current report
No Data